华法林治疗。1. - Suppr

Suppr

超能文献

Warfarin therapy. 1.

作者信息

Deykin D

出版信息

N Engl J Med. 1970 Sep 24;283(13):691-4. doi: 10.1056/NEJM197009242831307.

DOI:10.1056/NEJM197009242831307

PMID:4916914

Abstract

摘要

相似文献

Warfarin therapy. 1.

N Engl J Med. 1970 Sep 24;283(13):691-4. doi: 10.1056/NEJM197009242831307.

Factor VII during warfarin treatment.

Scand J Haematol. 1974;12(5):346-54. doi: 10.1111/j.1600-0609.1974.tb00220.x.

The liver and blood coagulation: physiology and pathology.

Gastroenterology. 1972 Aug;63(2):297-320.

Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.

Clin Nephrol. 1986 Feb;25(2):75-80.

Heparin therapy in the case of acute liver cirrhosis.

Scand J Gastroenterol Suppl. 1973;19:135-8.

Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.

Blood Coagul Fibrinolysis. 2009 Jul;20(5):358-65. doi: 10.1097/MBC.0b013e32832aa68c.

Warfarin. From bedside to bench.

N Engl J Med. 1984 Sep 6;311(10):645-52. doi: 10.1056/NEJM198409063111007.

Correlation between different intensities of anti-vitamin K treatment and coagulation parameters.

Thromb Res. 2000 Jun 15;98(6):467-71. doi: 10.1016/s0049-3848(00)00203-6.

Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism.

J Fam Pract. 1979 May;8(5):923-7.

Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.

J Clin Invest. 1993 Nov;92(5):2131-40. doi: 10.1172/JCI116814.

引用本文的文献

Reversal of anticoagulation in patients with intracerebral haemorrhage related to oral anticoagulants: State of the evidence.

Eur Stroke J. 2025 Apr;10(1_suppl):14-23. doi: 10.1177/23969873241281477. Epub 2025 May 22.

A Real-World, Prospective, Observational Study of Rivaroxaban on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-Valvular Atrial Fibrillation: XARENAL.

Korean Circ J. 2025 Feb;55(2):121-131. doi: 10.4070/kcj.2024.0154. Epub 2024 Oct 23.

Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity.

iScience. 2022 Jun 7;25(7):104547. doi: 10.1016/j.isci.2022.104547. eCollection 2022 Jul 15.

Warfarin resistance: possibilities to solve this problem. A case report.

J Int Med Res. 2022 Jun;50(6):3000605221103959. doi: 10.1177/03000605221103959.

Body mass index predicts major bleeding risks in patients on warfarin.

J Thromb Thrombolysis. 2015 Nov;40(4):494-8. doi: 10.1007/s11239-015-1226-2.

New oral anticoagulants: discussion on monitoring and adherence should start now!

Thromb J. 2013 Jun 28;11(1):8. doi: 10.1186/1477-9560-11-8.

Cardiovascular manifestations of hypereosinophilic syndromes.

Immunol Allergy Clin North Am. 2007 Aug;27(3):457-75. doi: 10.1016/j.iac.2007.07.001.

Warfarin: a review with emphasis on its use in the horse.

Can Vet J. 1983 Jul;24(7):211-3.

Effects of sodium warfarin on capillary ultrastructure.

Am J Pathol. 1971 Oct;65(1):149-56.

Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Clin Pharmacokinet. 1986 Nov-Dec;11(6):483-504. doi: 10.2165/00003088-198611060-00005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验